84. Leadership insights, Paul Biondi, President, Pioneering Medicines,Flagship Pioneering initiative
Paul Biondi, Executive Partner, Flagship Pioneering and President, Pioneering Medicines Paul joined Flagship Pioneering in 2019 as Executive Partner, Flagship Pioneering and President, Pioneering Med...
5 Tammi 202241min
83. Season 2 Wrap Up, Rahul Chaturvedi and Alok Tayi
Thank you for your support for Season 2! We reflect and look forward to Season 3 on this episode! Learn more about our co-hosts below! Alok Tayi, PhD is the Co-founder and CEO of Vibe Bio. Vibe is a ...
15 Joulu 20216min
82. RNA therapeutics for neurological indications, Barry Ticho, CMO, Stoke Therapeutics
As Chief Medical Officer Dr. Ticho is responsible for Stoke’s efforts to develop first-in-class RNA based disease-modifying medicines to treat severe genetic diseases. He is also co-founder and former...
8 Joulu 202127min
81. Innovations for narcolepsy, Greg Divis, CEO, Avadel Pharmaceuticals
Gregory J. Divis serves as Avadel’s Chief Executive Officer and a member of Avadel’s Board of Directors. Greg was appointed CEO in June of 2019, after previously serving in several leadership roles wi...
1 Joulu 202124min
80. Targeted cancer immunotherapies, Chip Clark, President and CEO, Genocea
Chip has served as Genocea's President and Chief Executive Officer since February 2011 after serving as Chief Business Officer from August 2010 to February 2011. Chip has also served on Genocea's boar...
17 Marras 202129min
79. Leadership in rare diseases, Srini Ramanathan, SVP, R&D Sciences, Horizon Therapeutics
Srini Ramanathan, Ph.D., Senior Vice President, Research and Development Sciences Srini Ramanathan, Ph.D., joined Horizon Therapeutics in 2018. He leads Horizon’s research and development sciences, w...
10 Marras 202127min
78. Translating lab insights for outcomes to cancer patients, Heike Keilhack, CSO,Ribon Therapeutics
Dr. Keilhack is an accomplished cancer biologist with rich experience in cell biology, animal models of cancer, pharmacology and translational medicine with over 15 years of experience in oncology dru...
3 Marras 202129min
77. Battling rare diseases: patients and scientists, Ethan Perlstein, Founder and CEO, Perlara
Dr. Ethan Perlstein is the founder and CEO of Perlara PBC, the first biotech public benefit company established in 2014 that partners with highly motivated and entrepreneurial families and foundations...
27 Loka 202126min
